Full Text
COST-UTILITY ANALYSIS IN HEPATITIS C VIRUS GENOTYPE 3 INFECTION- COMPARING THE NEW 12-WEEK REGIMEN WITH OTHER STANDARD THERAPIES

Abstract

Authors

N. Gangan Y. Yang

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×